Results 21 to 30 of about 386,538 (49)

Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.

Neuro-Oncology, 2016
This guideline provides recommendations for the use of PET imaging in gliomas. The review examines established clinical benefit in glioma patients of PET using glucose ((18)F-FDG) and amino acid tracers ((11)C-MET, (18)F-FET, and (18)F-FDOPA).
N. Albert, M. Weller, B. Suchorska, N. Galldiks, R. Soffietti, Michelle M. Kim, Christian la Fougère, W. Pope, I. Law, J. Arbizu, M. Chamberlain, M. Vogelbaum, B. Ellingson, J. Tonn   +13 more
semanticscholar   +1 more source

Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0

European Journal of Nuclear Medicine and Molecular Imaging, 2018
These joint practice guidelines, or procedure standards, were developed collaboratively by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neurooncology (EANO)
I. Law, N. Albert, J. Arbizu, R. Boellaard, A. Drzezga, N. Galldiks, Christian la Fougère, K. Langen, E. Lopci, V. Lowe, J. McConathy, H. Quick, B. Sattler, D. Schuster, J. Tonn, M. Weller   +15 more
semanticscholar   +1 more source

FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC

European Journal of Nuclear Medicine and Molecular Imaging, 2018
Large vessel vasculitis (LVV) is defined as a disease mainly affecting the large arteries, with two major variants, Takayasu arteritis (TA) and giant cell arteritis (GCA).
R. Slart, Riemer H. J. A. Andor W. J. M. Panithaya Giorgio Florent Slart Glaudemans Chareonthaitawee Treglia Besson B, R. Slart, A. Glaudemans, P. Chareonthaitawee, G. Treglia, F. Besson, T. Bley, D. Blockmans, R. Boellaard, J. Bucerius, J. Carril, Wengen Chen, M. Cid, Bhaskar Dagupta, S. Dorbala, O. Gheysens, F. Hyafil, Shaifali Jain, T. Klink, C. J. van der Laken, F. Lomeña, M. Massollo, S. Prieto-González, R. Luqmani, A. Roivainen, C. Salvarani, A. Saraste, M. Schirmer, H. Verberne, A. Versari, A. Voskuyl, M. Walter, D. Camellino, E. Brouwer, M. Cimmino, Aiden Denis Rob S. Roberto C. Andrew J. Alessia Edward J Abidov Agostini Beanlands Delgado-Bolton Einstein , A. Abidov, D. Agostini, R. Beanlands, R. Delgado-Bolton, A. Einstein, A. Gimelli, E. Miller, R. Sciagrà, A. Signore, Riemer H. J. A. Jan Fabien Hein J. Denis Alessia Roberto Slart Bucerius Hyafil Verberne Agostini Gimelli Sc, Andor W. J. M. Giorgio Olivier Annibale Alberto Glaudemans Treglia Gheysens Versari Signore, Panithaya Wengen Sharmila Chareonthaitawee Chen Dorbala, Andor W. J. M. Giorgio Florent L. Thorsten A. Daniel Ron Glaudemans Treglia Besson Bley Blockmans Boellaard, A. Roivainen, Panithaya Sharmila Aiden Rob S. Andrew J. Edward J. Chareonthaitawee Dorbala Abidov Beanlands Einstein   +51 more
semanticscholar   +1 more source

Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT

Journal of Nuclear Medicine, 2017
Prostate-specific membrane antigen (PSMA)–ligand PET imaging provides unprecedented accuracy for whole-body staging of prostate cancer. As PSMA-ligand PET/CT is increasingly adopted in clinical trials and routine practice worldwide, a unified language ...
M. Eiber, K. Herrmann, J. Calais, B. Hadaschik, F. Giesel, M. Hartenbach, T. Hope, R. Reiter, T. Maurer, W. Weber, W. Fendler   +10 more
semanticscholar   +1 more source

Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients

European Journal of Nuclear Medicine and Molecular Imaging, 2017
PurposeSince the clinical introduction of 68Ga-PSMA-11 PET/CT, this imaging method has rapidly spread and is now regarded as a significant step forward in the diagnosis of recurrent prostate cancer (PCa).
A. Afshar-Oromieh, T. Holland-Letz, F. Giesel, C. Kratochwil, W. Mier, S. Haufe, Nils Debus, M. Eder, M. Eisenhut, M. Schäfer, O. Neels, M. Hohenfellner, K. Kopka, H. Kauczor, J. Debus, U. Haberkorn   +15 more
semanticscholar   +1 more source

Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy

Journal of Nuclear Medicine, 2015
The expression of prostate-specific membrane antigen (PSMA) is increased in prostate cancer. Recently, 68Ga-PSMA (Glu-NH-CO-NH-Lys-(Ahx)-[68Ga(HBED-CC)]) was developed as a PSMA ligand.
M. Eiber, T. Maurer, M. Souvatzoglou, A. Beer, A. Ruffani, B. Haller, F. Graner, H. Kübler, Uwe Haberhorn, M. Eisenhut, H. Wester, J. Gschwend, M. Schwaiger   +12 more
semanticscholar   +1 more source

When pets become pests: the role of the exotic pet trade in producing invasive vertebrate animals

Frontiers in Ecology and the Environment, 2019
Author(s): Lockwood, JL; Welbourne, DJ; Romagosa, CM; Cassey, P; Mandrak, NE; Strecker, A; Leung, B; Stringham, OC; Udell, B; Episcopio-Sturgeon, DJ; Tlusty, MF; Sinclair, J; Springborn, MR; Pienaar, EF; Rhyne, AL; Keller, R | Abstract: © 2019 The ...
J. Lockwood, D. Welbourne, Christina M. Romagosa, P. Cassey, N. Mandrak, A. Strecker, B. Leung, Oliver C. Stringham, B. Udell, Diane J. Episcopio-Sturgeon, M. Tlusty, J. S. Sinclair, Michael R. Springborn, E. Pienaar, A. Rhyne, R. Keller   +15 more
semanticscholar   +1 more source

The Impact of 68Ga-PSMA PET/CT on Management Intent in Prostate Cancer: Results of an Australian Prospective Multicenter Study

Journal of Nuclear Medicine, 2018
68Ga-PSMA PET/CT scanning has been shown to be more sensitive than conventional imaging techniques in patients with prostate cancer. This prospective Australian multicenter study assessed whether 68Ga-PSMA PET/CT imaging affects management intent in ...
P. Roach, R. Francis, L. Emmett, E. Hsiao, A. Kneebone, G. Hruby, T. Eade, Quoc Nguyen, Benjamin D Thompson, T. Cusick, M. McCarthy, Colin I. Tang, B. Ho, P. Stricker, A. Scott   +14 more
semanticscholar   +1 more source

Matched-Pair Comparison of 68Ga-PSMA-11 PET/CT and 18F-PSMA-1007 PET/CT: Frequency of Pitfalls and Detection Efficacy in Biochemical Recurrence After Radical Prostatectomy

Journal of Nuclear Medicine, 2019
18F-labeled prostate-specific membrane antigen (PSMA)–ligand PET has several principal advantages over 68Ga-PSMA-11. The purpose of this retrospective study was to evaluate the frequency of non–tumor-related uptake and the detection efficacy comparing ...
I. Rauscher, M. Krönke, M. König, A. Gafita, T. Maurer, T. Horn, K. Schiller, W. Weber, M. Eiber   +8 more
semanticscholar   +1 more source

Using a marine microalga as a chassis for polyethylene terephthalate (PET) degradation

Microbial Cell Factories, 2019
BackgroundThe biological degradation of plastics is a promising method to counter the increasing pollution of our planet with artificial polymers and to develop eco-friendly recycling strategies.
D. Moog, J. Schmitt, J. Senger, J. Zarzycki, K. Rexer, U. Linne, T. Erb, U. Maier   +7 more
semanticscholar   +1 more source